Additional Details

  • Dates:March 9th 2019
  • CME Points:8.50
Show all
  • conducted by:Indy Hematology Education, Inc


Interested to attend a conference, a full day of presentations by today’s leaders in Hematology and Hematologic Malignancies ?

Here is an excellent opportunity!

Save the Dates!

The Indy Hematology Education, Inc conducting the 16th Annual Indy Hematology Review 2019

Indy Hematology Education, Inc. is a 501(c), non-profit corporation, incorporated on February 15, 2010, in the State of Indiana, with the following purposes:

(a) Raise awareness and provide education regarding hematology and oncology diseases and disorders

(b) To encourage youth to pursue careers in hematology and oncology and

(c) To connect individuals suffering from or affected by hematology and oncology diseases and disorders to organizations, programs, and service providers.


Conference Location: JW Marriott Indianapolis 10 S. West Street Indianapolis, IN

Conference Dates: March 9th 2019


Registration Fees

Early Bird Registration: ends February 1, 2019 Early Bird Physicians – $185.00

Early Bird Physicians + CME Fee – $210.00

Early Bird Allied Health & Nurses – $110.00

Early Bird Allied Health & Nurses + CNE Fee – $135.00

Early Bird Nurse Practitioners & Pharmacists – $135.00

Early Bird Nurse Practitioners & Pharmacists + CPE Fee – $160.00

Industry & Exhibitors $360.00 Standard Registration: after February 1, 2019 Physicians – $235.00 Physicians + CME Fee $260.00 Allied Health & Nurses – $160.00

Allied Health & Nurses + CNE Fee – $185.00

Nurse Practitioners & Pharmacists – $185.00

Nurse Practitioners & Pharmacists + CPE Fee $210.00 Industry & Exhibitors – $360.00 Student/Fellow Scholarship* (Limited Number) – $25.00

Nurse Scholarship* (Limited Number) – $25.00


Learning Objectives

At the completion of this activity, participants should be able to:

  1. Discuss new emerging hematology therapies in general and for chronic Myeloid Leukemia, acute Promyelocytic and Myeloid Leukemia, and Myeloproliferative neoplasms.
  2. Evaluate molecular diagnosis, targeted therapies, and resistance mechanisms of Waldenström’s Macroglobulinemia to assist in disease recognition.
  3. Discuss the advancement of immune checkpoint inhibitors within hematologic malignancies and updated treatment paradigms presented at the American Society of Hematology meeting in San Diego, CA in December 2018.
  4. Recommend new regimens for Hematopoietic Stem Cell transplantation and identification of transplant candidates.
  5. Review the advancement in benign hematology research.
  6. Review new treatment regimens in follicular lymphoma.


Conference Description

Gain comprehensive clinical content that will immediately impact your practice. This full-day symposium features a series of didactic lectures presented by the nation’s top hematology experts from the Dana-Farber Cancer Institute, MD Anderson Cancer Center, Johns Hopkins School of Medicine, Lombardi Comprehensive Cancer Center, Mayo Clinic, and more! The Indy Hematology Review brings together over 300 hematologists, oncologists, radiologists, physician assistants, oncology RN’s, nurse practitioners, pharmacists, medical students, and other allied health professionals. Stay current with a concise summary of the critical data presented at the American Society of Hematology (ASH) annual meeting. Examine significant scientific updates in clinical hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into new patient care strategies.